Scans were processed and the cartilage was manually segmented. Average 3D cartilage thickness (Cg.Th) was calculated for the medial and lateral tibial plateaux. Joints were dissected, fixed in buffered formalin, and embedded in paraffin for histology processing with Safranin O-Fast Green. Registration of histology and microCT images allowed identification of the corresponding microCT slice. 2D Cg.Th from both images was calculated and correlated. Results: A sagittal view of a typical healthy knee joint (Fig. 1) shows the clearly defined cartilage between bone and joint space (contrast agent). The correlation between Cg.Th obtained from histology and microCT is depicted in figure 2a. Correlations were similar for OA-induced and healthy rat knees, therefore the data was pooled to give a correlation, R ¼ 0.89, p < 0.001. Additional 3D assessment of the cartilage was also achieved. The central medial load-bearing surface of a typical healthy 3D sample (Fig. 2b) shows regions of thicker cartilage compared to the same region, subject to erosion, in the OA model (Fig. 2c) . With the segmentation of joint components, sample specific images can be generated (Fig. 3) .
COMPARATIVE PROTEOMIC ANALYSIS OF BONE MARROW MESENCHYMAL STEM CELLS FROM OA AND HEALTHY PATIENTS UNDERGOING CHONDROGENIC DIFFERENTIATION
B. Rocha, J. Mateos, V. Calamia, C. Ruiz-Romero, F.J. Blanco. Osteoarticular and Aging Res. Lab., Proteomics Unit-Associated Node to ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña, Spain Purpose: Mesenchymal stem cells (MSCs) play a key role in normal cartilage turnover and repair. MSCs participate in these processes through their capacity to differentiate towards chondrocytes and their skill to migrate to the site of injury. Osteoarthritis (OA) is a disease characterized by an imbalance in cartilage homeostasis, which might be corrected by MSC-based therapies. To identify potential molecular mediators of OA pathogenesis, we have performed a quantitative proteomic analysis of bone marrow MSCs undergoing chondrogenic differentiation, which were obtained from OA patients (n¼3) and control donors (n¼3) using a de novo protein labeling approach (SILAC). Methods: Bone marrow MSCs from normal and OA patients were expanded in monolayer cultures with a DMEM medium lacking arginine and lysine. Regular L-lys and L-arg were added to the normal cell population media, whereas isotope-labeled L-lys (Lys6) and L-arg (Arg10) forms were added to the OA cell population media. Once complete incorporation of the isotopes was achieved, both types of cells were grown in a three-dimensional (3D) environment (micromasses) during a period of 14 days in a commercial chondrogenic medium, to promote chondrogenesis. Expression of cartilage specific genes and histological assays were performed to explore the chondrogenicity of MSCs. For the proteomic analysis, protein samples from OA (heavy) and normal (light) micromasses were combined at a 1:1 ratio. Protein mixtures were then separated by SDS-PAGE before in-gel digestion with trypsin. Separation of the resulting tryptic peptides was performed by nanoscale LC-MS/MS. Identification and quantification of proteins was carried out with Protein Pilot 3.0 software. Results: A significant difference in the gene expression of collagen type II was observed in the normal donors when compared to the OA patients. Moreover, histology assays confirmed that both types of cells exhibited aggrecan and sulfated glycosaminoglycans formation after 14 days in chondrogenesis. Using SILAC, we compared the intracellular protein profiles of OA and normal bone marrow MSCs at the same time of differentiation. Among the 417 quantified proteins, 77 had significantly altered levels. 46 proteins displayed consistently higher levels in the OA samples compared to normal donors. Among them, we found some matrix-regulatory agents like Serpin H1 and Galectin-3. We also found other heat shock proteins, like Endoplasmin, with the same expression pattern. On the other hand, 31 proteins displayed a significantly reduced expression in OA patients when compared to controls. Interestingly, we detected proteins that are involved in the regulation of cell morphology and cytoskeletal organization, like Destrin or Fascin, pointing to a lower actin turnover in MSCs from OA patients.
Conclusions: We applied quantitative proteomics to characterize the specific modulations in the protein profiles of bone marrow MSCs from OA and healthy patients cultured in an in vitro model of chondrogenesis. The majority of modulated proteins have not been described to participate in this differentiation process. Moreover, the increased expression of some of them in OA patients (like Serpin H1), suggest their putative role in the abnormal cell differentiation that might contribute to the development of the disease. 1 Inserm U844, Montpellier, France; 2 EFS-PM, Toulouse, France Purpose: Mesenchymal stem or stromal cells (MSC) isolated from bone marrow (BM-MSC) or adipose tissues (ASC) are currently investigated in regenerative medicine for their capacities to repair injured tissues. In osteo-articular pathologies, they may be useful in counteracting inflammatory and/or degenerative joint diseases via the secretion of various factors with immunomodulatory, proliferative, anti-fibrotic or anti-apoptotic properties. The objective of this study was to determine the safety and biodistribution of human ASC that have been expanded Abstracts / Osteoarthritis and Cartilage 20 (2012) S10-S53 S51
